BAKER BROS. ADVISORS LP 13D and 13G filings for Rhythm Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:21 pm Purchase |
2023-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
BAKER BROS. ADVISORS LP | 6,398,365 10.800% |
43,757 (+0.69%) |
Filing |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
BAKER BROS. ADVISORS LP | 6,354,608 11.300% |
291,906 (+4.81%) |
Filing |
| 2022-10-07 4:20 pm Purchase |
2022-09-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
BAKER BROS. ADVISORS LP | 6,062,702 10.900% |
2,199,463 (+56.93%) |
Filing |
| 2022-02-14 4:17 pm Purchase |
2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
BAKER BROS. ADVISORS LP | 3,863,239 7.700% |
1,548,366 (+66.89%) |
Filing |
| 2021-02-16 5:04 pm Sale |
2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
BAKER BROS. ADVISORS LP | 2,314,873 5.200% |
-393,327 (-14.52%) |
Filing |